Healthcare execs to Biden: Use AI, big data to tackle health equity To view this email as a web page,
click here AstraZeneca scores win in Europe's COVID-19 vaccine lawsuit, saying it can easily beat court supply mandate U.K. doubles down on Innova's rapid COVID-19 test, after FDA urged users to throw it away Healthcare executives call on Biden to take 'innovative, bold' steps to tackle health equity using AI, big data Moderna plots 155 new hires in 2021 amid major mRNA vaccine manufacturing expansion COVID-19 tracker: Biden says U.S. headed toward summer of 'joy and freedom'; Innova's troubled test wins UK backing Can semiconductor expertise be applied to biopharma manufacturing? Entegris bets $40M that it can Featured Story | By Eric Sagonowsky As Europe battled the COVID-19 pandemic and looked to AstraZeneca for a much-needed vaccine, officials there took an unusual step earlier this year of suing the company over supply shortcomings. But in a significant win for the drugmaker, a Brussels court mostly sided with the company in that case. read more |
| |
|---|
|
| | Who’s Watching Your Clinical Trial Supply Chain? With the ever-increasing costs of clinical trials and the advantages of being first-to-market, it’s time to take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within your budget. Learn about key strategies for mitigating risk in clinical trials. Learn more. |
Top Stories By Conor Hale After the FDA urged anyone who had Innova Medical Group’s COVID-19 antigen test to stop using it and toss it in the trash, regulators across the pond have re-reviewed and now cleared the rapid diagnostic's use, while also extended its authorization. read more By Dave Muoio More work to collaboratively analyze and act upon social determinants data will spur better outcomes and lower costs, according to provider and payer executives. read more By Angus Liu With a major COVID-19 vaccine manufacturing boost underway, Moderna is plotting new hires to fill its expanded production and lab space. The mRNA specialist has promised to hire at least 155 new employees in Massachusetts as part of a state tax incentive. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner President Joe Biden said the U.S. could see a summer of "joy and freedom" but warned that the rapidly-spreading Delta variant could pose a threat to unvaccinated Americans. Innova's rapid COVID-19 test, slammed by the FDA just a week ago, won support from U.K. regulators. And more headlines. read more By Kevin Dunleavy Entegris, a Massachusetts-based manufacturer of assemblies for semiconductors, is investing $40 million in its life sciences division. The company believes its expertise is a natural fit for the production of medicines. read more |
|
